Bruce P.Robinson, MD

a New Treatment regime for Basal & SQUAMOUS Cell Carcinoma

Fractional Laser - non-invasive treatment proves extremely effective in the treatment of skin cancer

Bruce Robinson, MD is pioneering a transformative new treatment option for the most common forms of skin cancer: Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC).

It involves a combination of Fractional Laser therapy and topical medication. The results have been dramatic: almost complete elimination of BCCs and SCCs, requiring only ONE very short treatment, with minimal disruption for the patient, and an excellent visual end result.

The use of fractional lasers to wipe out BCCs or SCCs promises to open a whole new chapter in skin cancer treatment, and Dr. Robinson is expanding his research and healing in this area.


Basal Cell Carcinoma is the most common form of skin cancer – in fact it is the most common form of any cancer, with 3.6 million cases diagnosed yearly. BCC is slow growing and can be cured if dealt with early. However, if left untreated, BCC can grow locally and reoccur.

Past treatments have included surgical excision, freezing, topical creams, even radiation. However, since 2023 Bruce Robinson, MD has been pioneering a new approach using fractional lasers on the skin followed by topical medication. With this combination he has achieved remarkable results, including a cancer clearing rate approaching 100% upon follow-up visits.

Basal or squamous cell carcinomas are not the same as melanoma skin cancer. They are most often a result of sun damage. As the most common forms of skin cancer, they account for 90% of skin cancers in the U.S. Traditional therapies have included:

  • Cutting out or “excising” the tumor (including Mohs surgery), which includes removing a small surrounding area of normal-appearing skin and sending it to a lab. If lab results reveal cancer cells in the area around the tumor, more skin may need to be removed.
  • Scraping the tumor away and using electricity to kill cancer cells, also known as "curettage and desiccation."
  • Freezing cancer cells, known as "cryosurgery" using liquid nitrogen.

Dr. Robinson’s unique approach combines Fractional Laser therapy alongside proven topical medication. Fractional lasers have been used by dermatologists for decades to treat minor facial flaws and improve skin appearance. Dr. Robinson’s breakthrough approach has been to extend their use deeper into the skin to kill off cancer cells while minimizing damage to surrounding cells. The non-ablative fractional laser promises to be a new and innovative approach to skin cancer treatment without excision or stitches, risk of infection, physical limitations, or prolonged recovery time. Dr. Robinson is currently expanding his research and notable advancement in skin cancer treatment using these novel approaches and targeted therapies to improve patient outcomes and survival rates.

Words from Dr. Robinson

In a world where battling skin cancers often leaves behind scars and lengthy recovery times, I sought -- and found -- a different path. I discovered the potential of fractional laser therapy coupled with a specialized topical medication.

The concept was simple yet revolutionary - the laser would create microscopic treatment zones in the skin to destroy the skin cancer while allowing the topical medication to penetrate deeply and target the cancerous cells effectively. Not only would this treatment clear the current skin cancers, but it also held the promise of reducing the likelihood of future occurrences at the treated site, thanks to the combined effects of the laser and the topical medication.

With each successful treatment, I have found renewed purpose in helping patients navigate their skin cancer journey with minimal complications. My passion for using cutting-edge technology to clear skin cancers while preserving the natural beauty of my patients drove me to explore new possibilities and reach more individuals in need. With each new testimonial from satisfied patients, I am proud knowing that I found a way to help others avoid the burden of scars and lengthy healing times in their battle against skin cancer.

Who is at risk to develop Basal Cell Carcinoma or Squamous Cell Carcimona?

Basal Cell Carcinoma (BCC) is a type of skin cancer that can affect anyone, but certain factors can increase the risk of its development. If you fall into any of the following categories, you may have a greater likelihood of developing BCC:

  • Age over 50
  • Fair Skin
  • Lack of Sun Protection
  • UV Exposure from Indoor Tanning
  • Gender
  • History of Skin Cancer

Squamous Cell Carcinoma (SCC) is another common form of skin cancer, and certain factors can increase the risk of developing SCC:

  • Age over 50
  • Fair Skin
  • UV Exposure
  • Tanning Bed Use
  • Previous Radiation Exposure
  • Weakened Immune System
  • Chronic Skin Inflammation or Injury
  • History of Skin Cancer

Recognizing the signs of Basal and Squamous Cell Carcinomas is crucial for early detection and effective treatment. These cancers can manifest in various forms, including:

  • An open sore that doesn't heal.
  • A sore that repeatedly heals and returns in the same location.
  • A reddish, irritated-looking patch of skin.
  • A shiny bump on the skin.
  • A small pink growth with a slightly raised edge and a crusty dent in the middle.

While no one is immune to skin cancer, it is essential for individuals with these risk factors to be vigilant about monitoring their skin for any unusual changes, such as persistent sores, rough or scaly patches, or changes in existing moles. Regular skin checks by a dermatological specialist are crucial for early detection and timely intervention.


Efficacies and Benefits of Fractional Laser Treatment

The efficacy and benefits of fractional laser treatment for Basal and Squamous Cell Carcinoma (BCC and SCC) are indeed impressive and offer a multitude of advantages for patients:

  • Non-Invasiveness
  • Suitable for Specific Patient Profiles
  • Minimal Downtime and Quick Healing
  • Recurrence Prevention
  • Low Infection Rate
  • Cost-Effective
  • Decreased Anxiety
  • Field Effect of Treatment
  • Rapid Procedure
  • Safety
  • Minimal Risk of Postoperative Complications
  • Appealing to Cosmetic Concerns
  • Additional Advantages for Specific Groups:
    • No Bleeding: Advantageous for patients on anticoagulants who do not need to stop their medications before, during and for some time after the procedure.
    • Not Invasive for Infirm or Older Patients: Older or infirm patients may not tolerate more-invasive procedures, multiple procedures, or the need to treat an area that would require a skin flap or graft.
    • Great for Actors or Public Figures: Individuals benefit from the minimal or complete lack of scarring and quick recovery times.
    • Excellent for atheletes, sports figures, and  "weekend warriors" who can return immediately to their chosen activities.

In summary, fractional laser therapy emerges as a highly effective, safe, and patient-friendly approach to treating Basal and Squamous Cell Carcinomas. Its non-invasive nature, quick healing, minimal scarring, and efficacy in preventing recurrences make it an valuable option for a diverse range of patients seeking effective and aesthetically pleasing skin cancer treatment.


The Fraxel laser in the skilled hands of Bruce Robinson, MD

The Hows and Whys of the Fractional Laser

The Fractional laser, a tool typically employed for skin resurfacing to enhance appearance, has found a groundbreaking application in the hands of Dr. Robinson for the treatment of Basal and Squamous Cell Carcinomas. Here's an exploration of how and why this innovative approach works:

  1. Microscopic Treatment Zones and Topical Medication Synergy:
    The laser creates microscopic treatment zones at a specific level in the skin. These not only efficiently destroy cancerous cells but also play a crucial role in enhancing the penetration of the topical medication, reaching deeper skin layers to more directly destroy skin cancer cells.
  2. Topical Medication: A topical medication is applied nightly, which penetrates deeply into the skin, targeting and further eliminating cancerous cells.
  3. Bulk Heating: The fractional laser treatment generates bulk heating in the skin, which  contributes to the destruction of skin cancer beyond the microscopic zones. The increased temperature also tightens the skin and stimulates the production of collagen for repair.
  4. Non-Ablative Nature: The fractionated laser utilizes less energy compared to ablative lasers. Ablative lasers, by contrast, completely remove the outer layer of the skin, leading to longer recovery times.
  5. Short-Duration of Treatment and The Field Effect: The treatment offers a quicker, more  efficient solution for clearing current skin cancers. The combined effects of fractional laser and topical medication show evidence of reducing the likelihood of future occurrences at the treated site and surrounding skin.

Before & After
Fractional Laser Treatment

Case Study: RL’s Triumph Over Skin Cancer

In the realm of dermatology, the journey of treating skin cancers often unfolds in a series of delicate decisions, aiming to balance efficacy, patient comfort, and cosmetic outcomes. For over three decades, I have been privileged to witness the evolution of treatments, but none have been as rewarding and transformative as the fractional laser approach in the case of my patient, RL.

RL, a resilient individual, had battled multiple skin cancers over the years, navigating through surgical excisions and recoveries. However, recent developments in his health, including the onset of Parkinson's disease and confinement to a wheelchair, presented new challenges. As fate would have it, RL was diagnosed with two basal cell carcinomas on his face and a squamous cell carcinoma on his chest, demanding prompt attention.

Traditionally, surgical options, including Mohs surgery, would have been the norm. However, the unique circumstances surrounding RL’s health prompted a reevaluation of the treatment approach. The fractional laser, coupled with a topical medication regimen spanning only five days, emerged as a beacon of hope.

The decision to opt for fractional laser treatment was rooted in its ability to offer numerous advantages over traditional surgical methods. The most striking benefit was the efficiency and convenience it brought to someone like RL, whose mobility challenges made traditional procedures nearly impossible. The fractional laser treatment took a mere 5 minutes per lesion, allowing RL to have all three skin cancers addressed in less than 15 minutes during a single visit...


TAKE ACTION: ScHeduLe a COnsultation

Skin concerns should never be taken lightly, and early detection can make a significant difference in treatment outcomes. Early signs of Basal and Squamous Cell Carcinoma can manifest in various ways, and prompt evaluation is crucial. If you've noticed any changes in your skin, such as a pink or reddish spot, rapidly growing growths, or persistent sores that refuse to heal, we strongly encourage you to reach out to our office.

Dr. Robinson, a board-certified dermatologist with over 30 years of experience, is here to assist you. His expertise allows for a thorough examination and accurate diagnosis of any skin irregularities you may be experiencing. Fractional Laser has proven to be an effective and innovative solution for treating various skin conditions including skin cancers, providing optimal results under Dr. Robinson's skilled hands.

We welcome the opportunity to address your questions and provide you with the information you need to make an informed decision. To schedule an appointment or if you have any inquiries, please don't hesitate to call our office at 212-750-7121 or complete the adjacent form.

Contact Form
NOTE: As a new theraputic treatment being used in an experimental trial, the trial may not result in successful treatment of your Basal or Squamous Cell Carcinoma. You agree to follow up at 1, 6 and 12 months after the initial treatment so Dr. Robinson can assess the treatment site. If the treated area shows recurrence of the Basal or Squamous Cell Carcinoma during the post-op observation period,  surgical excision may be required.
Bruce Robinson: New York Super Doctor 2023Bruce Robinson: New York Top Doctor 2023Bruce Robinson: New York Super Doctor 2022Bruce Robinson: New York Top Doctor 2022
Copyright © 2024 Bruce Robinson, MD • All Rights Reserved
magnifiercross linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram